Who are CSL Limited's main suppliers?

CSL Limited (CSLLY) key suppliers include: Arcturus Therapeutics Holdings Inc., Haemonetics Corporation, Immuron Limited, Travere Therapeutics, Inc.. View the full supplier network at chainsifter.com/chain/CSLLY.

Who are CSL Limited's major customers?

CSL Limited (CSLLY) key customers include: Haemonetics Corporation, Travere Therapeutics, Inc., Vaxart, Inc.. View the full customer network at chainsifter.com/chain/CSLLY.

What sector is CSL Limited in?

CSL Limited (CSLLY) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

CSL Limited Supplier List (CSLLY): 4 Verified Suppliers

4Suppliers

3Customers

1Debt Items

20Related Chains

Source-Backed Evidence Depth

CSL Limited (CSLLY) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

9Total relationships

0Distinct source URLs

2High confidence

0.760Average confidence

2026-09-13Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

CSL Limited Suppliers

Ticker	Name	Confidence	Evidence
ARCT	Arcturus Therapeutics Holdings Inc.	72%	Reciprocal relationship from ARCT graph: Reciprocal relationship from CSLLY graph: Reciprocal relationship from ARCT graph: Reciprocal relationship from CSLLY graph: Reciprocal relationship from ARCT…
HAE	Haemonetics Corporation	72%	Reciprocal relationship from HAE graph: Reciprocal relationship from CSLLY graph: Reciprocal relationship from HAE graph: Reciprocal relationship from CSLLY graph: Reciprocal relationship from HAE gr…
IMRN	Immuron Limited	72%	Reciprocal relationship from IMRN graph: four-year period commencing one year from the effective date of the offering. Any proceeds from the exercise of the Representative’s Warrants will be added to…
TVTX	Travere Therapeutics, Inc.	72%	Reciprocal relationship from TVTX graph: Reciprocal relationship from CSLLY graph: Reciprocal relationship from TVTX graph: s of effective sales personnel; • lack of complementary products to be offe…

CSL Limited Customers

Ticker	Name	Confidence	Evidence
HAE	Haemonetics Corporation	72%	Reciprocal relationship from HAE graph: Item 13. Certain Relationships and Related Transactions and Director Independence 109 Item 14. Principal Accounting Fees and Services 109 Item 15. Exhibits, Fi…
TVTX	Travere Therapeutics, Inc.	72%	Reciprocal relationship from TVTX graph: s of effective sales personnel; • lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to …
VXRT	Vaxart, Inc.	72%	Reciprocal relationship from VXRT graph: Reciprocal relationship from CSLLY graph: Reciprocal relationship from VXRT graph: irements relating to the organization of personnel, buildings and facilitie…

CSL Limited Debt Obligations

Instrument	Description	Confidence	Evidence
CSLLY-DEBT	Debt stack $11.1B	90%	Market cache reports total debt of $11.1B.

CSL Limited Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for CSL Limited.

CSL Limited Ownership

Holder	Name	Confidence	Evidence
CSLLY-OWNER-YOUSIF-CAPITAL-MANAGEMENT-LLC	YOUSIF CAPITAL MANAGEMENT, LLC	90%	13F overlay lists YOUSIF CAPITAL MANAGEMENT, LLC as top holder; 7 tracked holders.

CSL Limited Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
VXRT	Vaxart, Inc.	100.00	1	['customer']
VERA	Vera Therapeutics, Inc.	100.00	2
IMRN	Immuron Limited	100.00	1	['supplier']
MIRM	Mirum Pharmaceuticals, Inc.	100.00	2
HAE	Haemonetics Corporation	100.00	1	['customer', 'supplier']
ARCT	Arcturus Therapeutics Holdings Inc.	100.00	1	['supplier']
JBIO	Jade Biosciences, Inc.	100.00	2
COCP	Cocrystal Pharma, Inc.	50.00	2
SGIOF	Shionogi & Co., Ltd.	50.00	2
MRK	Merck & Co., Inc.	50.00	2
HCRP	HCRP	50.00	2
FSNUY	Fresenius SE & Co. KGaA	50.00	2
EBS	Emergent BioSolutions Inc.	50.00	2
ABT	Abbott Laboratories	50.00	2
FDMT	4D Molecular Therapeutics, Inc.	50.00	2
SI	Shoulder Innovations, Inc.	50.00	2
JPM-PD	JPMorgan Chase & Co.	50.00	2
OKYO	OKYO Pharma Limited	50.00	2
PARI	PARI	50.00	2
ORANY	ORANGE	50.00	2

CSL Limited Supply Chain